Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Benbrook, Doris
One or more keywords matched the following items that are connected to Benbrook, Doris
Item TypeName
Concept Cell Division
Concept G1 Phase
Academic Article Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria.
Academic Article A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
Academic Article A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study.
Academic Article Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Academic Article Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
Academic Article Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Academic Article Complexity, retinoid-responsive gene networks, and bladder carcinogenesis.
Academic Article Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
Academic Article Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Academic Article A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.
Academic Article Retinoids and steroids regulate menstrual phase histological features in human endometrial organotypic cultures.
Academic Article A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.
Academic Article Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Academic Article A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
Academic Article Differential retinoic acid radiosensitization of cervical carcinoma cell lines.
Academic Article Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.
Academic Article A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.
Academic Article Immunohistochemical analysis of proliferation and differentiation in organotypic cultures of cervical tumor cell lines.
Academic Article Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells.
Grant Targeting HPV Consequences in a Cervical Cancer Clinical Trial
Grant Ovarian Cancer Chemoprevention
Search Criteria
  • Cell Division